|
US 11,890,333 B2 |
|
| Personalized immunotherapy against several neuronal and brain tumors |
| Sabrina Kuttruff-Coqui, Filderstadt-Sielmingen (DE); Toni Weinschenk, Aichwald (DE); Jens Fritsche, Dusslingen (DE); Steffen Walter, Houston, TX (US); Norbert Hilf, Kirchentellinsfurt (DE); Oliver Schoor, Tuebingen (DE); Colette Song, Ostfildern (DE); and Harpreet Singh, Munich (DE) |
| Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Jul. 30, 2021, as Appl. No. 17/390,583. |
| Application 17/390,583 is a continuation of application No. 17/165,638, filed on Feb. 2, 2021, granted, now 11,607,446. |
| Application 17/165,638 is a continuation of application No. 14/531,472, filed on Nov. 3, 2014, granted, now 10,946,064, issued on Mar. 16, 2021. |
| Claims priority of provisional application 61/899,680, filed on Nov. 4, 2013. |
| Claims priority of application No. 1319446 (GB), filed on Nov. 4, 2013. |
| Prior Publication US 2021/0369826 A1, Dec. 2, 2021 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 14/47 (2006.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61P 35/02 (2006.01); A61P 35/00 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01); C07K 14/705 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C12Q 1/6886 (2018.01) |
